Sequenom Inc., a diagnostics testing and genetic analysis company, said it would pay $14 million to settle an investor class-action lawsuit arising from mistakes in the development of a prenatal test for Down Syndrome.
Follow this link:
Sequenom in $14M settlement over test delay
Over the years, through our many assignments, the Principals of Revitalization Partners frequently said to ourselves: “One day, we should write a book about our work and how we can help companies through our experiences.” This is that book and we hope that you find words of value to you and your business.